Cell-cell and cell-matrix interactions in bone

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter covers the structure of bone, diseases associated with bones, functions of the bone cells, and hormones responsible for bone development, growth, and maintenance. Bone cells are in constant communication with cells of other systems and also with the extracellular matrix (ECM), which is composed of osteoid, non-mineralized bone tissue and the mineralized bone matrix. One of the bone diseases, osteoporosis is defined as the condition of generalized skeletal fragility in which bone strength is sufficiently weak that fractures occur with minimal trauma, often no more than is applied by routine daily activity. Treatment for osteoporosis includes hormone therapy and the use of bone resorption inhibitors such as the bisphosphonates, and, in addition, stimulators of bone formation such as modified forms of parathyroid hormone (PTH). Another serious genetic bone disease is osteogenesis imperfecta, a heritable disease of bone characterized by recurring bone fractures. It is caused by mutations affecting the structure of the collagen type I molecule, and is the most common single gene defect causing bone disease. One of the bone cells, osteoclast is described histologically as a multinucleated, tartrate-resistant acid phosphatase (TRAP)-positive cell. The sole function of the osteoclast is to resorb bone. Osteoclast precursors are derived from the same stem cell hematopoietic precursors that can become granulocytes and monocytes/macrophages. Cell lines such as RAW 267.4 and MOPC-5 are available that represent osteoclast precursors, as these cells can form TRAP-positive multinucleated cells that resorb bone. Osteocytes are terminally differentiated osteoblasts, making up the majority of all bone cells. During osteocyte ontogeny, the matrix producing osteoblast becomes either a lining cell or a pre-osteocyte embedded in the newly formed osteoid.

Original languageEnglish (US)
Title of host publicationHandbook of Cell Signaling, 2/e
PublisherElsevier Inc.
Pages2647-2662
Number of pages16
Volume3
ISBN (Print)9780123741455
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Cell Communication
Bone
Bone Diseases
Bone and Bones
Osteoclasts
Osteocytes
Inborn Genetic Diseases
Bone Development
Osteoblasts
Osteoporosis
Hormones
Bone Density Conservation Agents
Osteogenesis Imperfecta
Bone Matrix
Bone Fractures
Diphosphonates
Hematopoietic Stem Cells
Collagen Type I
Parathyroid Hormone
Granulocytes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bonewald, L. (2010). Cell-cell and cell-matrix interactions in bone. In Handbook of Cell Signaling, 2/e (Vol. 3, pp. 2647-2662). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374145-5.00313-2

Cell-cell and cell-matrix interactions in bone. / Bonewald, Lynda.

Handbook of Cell Signaling, 2/e. Vol. 3 Elsevier Inc., 2010. p. 2647-2662.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bonewald, L 2010, Cell-cell and cell-matrix interactions in bone. in Handbook of Cell Signaling, 2/e. vol. 3, Elsevier Inc., pp. 2647-2662. https://doi.org/10.1016/B978-0-12-374145-5.00313-2
Bonewald L. Cell-cell and cell-matrix interactions in bone. In Handbook of Cell Signaling, 2/e. Vol. 3. Elsevier Inc. 2010. p. 2647-2662 https://doi.org/10.1016/B978-0-12-374145-5.00313-2
Bonewald, Lynda. / Cell-cell and cell-matrix interactions in bone. Handbook of Cell Signaling, 2/e. Vol. 3 Elsevier Inc., 2010. pp. 2647-2662
@inbook{fc5691b4ac5544b0853f67dc33653282,
title = "Cell-cell and cell-matrix interactions in bone",
abstract = "This chapter covers the structure of bone, diseases associated with bones, functions of the bone cells, and hormones responsible for bone development, growth, and maintenance. Bone cells are in constant communication with cells of other systems and also with the extracellular matrix (ECM), which is composed of osteoid, non-mineralized bone tissue and the mineralized bone matrix. One of the bone diseases, osteoporosis is defined as the condition of generalized skeletal fragility in which bone strength is sufficiently weak that fractures occur with minimal trauma, often no more than is applied by routine daily activity. Treatment for osteoporosis includes hormone therapy and the use of bone resorption inhibitors such as the bisphosphonates, and, in addition, stimulators of bone formation such as modified forms of parathyroid hormone (PTH). Another serious genetic bone disease is osteogenesis imperfecta, a heritable disease of bone characterized by recurring bone fractures. It is caused by mutations affecting the structure of the collagen type I molecule, and is the most common single gene defect causing bone disease. One of the bone cells, osteoclast is described histologically as a multinucleated, tartrate-resistant acid phosphatase (TRAP)-positive cell. The sole function of the osteoclast is to resorb bone. Osteoclast precursors are derived from the same stem cell hematopoietic precursors that can become granulocytes and monocytes/macrophages. Cell lines such as RAW 267.4 and MOPC-5 are available that represent osteoclast precursors, as these cells can form TRAP-positive multinucleated cells that resorb bone. Osteocytes are terminally differentiated osteoblasts, making up the majority of all bone cells. During osteocyte ontogeny, the matrix producing osteoblast becomes either a lining cell or a pre-osteocyte embedded in the newly formed osteoid.",
author = "Lynda Bonewald",
year = "2010",
doi = "10.1016/B978-0-12-374145-5.00313-2",
language = "English (US)",
isbn = "9780123741455",
volume = "3",
pages = "2647--2662",
booktitle = "Handbook of Cell Signaling, 2/e",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cell-cell and cell-matrix interactions in bone

AU - Bonewald, Lynda

PY - 2010

Y1 - 2010

N2 - This chapter covers the structure of bone, diseases associated with bones, functions of the bone cells, and hormones responsible for bone development, growth, and maintenance. Bone cells are in constant communication with cells of other systems and also with the extracellular matrix (ECM), which is composed of osteoid, non-mineralized bone tissue and the mineralized bone matrix. One of the bone diseases, osteoporosis is defined as the condition of generalized skeletal fragility in which bone strength is sufficiently weak that fractures occur with minimal trauma, often no more than is applied by routine daily activity. Treatment for osteoporosis includes hormone therapy and the use of bone resorption inhibitors such as the bisphosphonates, and, in addition, stimulators of bone formation such as modified forms of parathyroid hormone (PTH). Another serious genetic bone disease is osteogenesis imperfecta, a heritable disease of bone characterized by recurring bone fractures. It is caused by mutations affecting the structure of the collagen type I molecule, and is the most common single gene defect causing bone disease. One of the bone cells, osteoclast is described histologically as a multinucleated, tartrate-resistant acid phosphatase (TRAP)-positive cell. The sole function of the osteoclast is to resorb bone. Osteoclast precursors are derived from the same stem cell hematopoietic precursors that can become granulocytes and monocytes/macrophages. Cell lines such as RAW 267.4 and MOPC-5 are available that represent osteoclast precursors, as these cells can form TRAP-positive multinucleated cells that resorb bone. Osteocytes are terminally differentiated osteoblasts, making up the majority of all bone cells. During osteocyte ontogeny, the matrix producing osteoblast becomes either a lining cell or a pre-osteocyte embedded in the newly formed osteoid.

AB - This chapter covers the structure of bone, diseases associated with bones, functions of the bone cells, and hormones responsible for bone development, growth, and maintenance. Bone cells are in constant communication with cells of other systems and also with the extracellular matrix (ECM), which is composed of osteoid, non-mineralized bone tissue and the mineralized bone matrix. One of the bone diseases, osteoporosis is defined as the condition of generalized skeletal fragility in which bone strength is sufficiently weak that fractures occur with minimal trauma, often no more than is applied by routine daily activity. Treatment for osteoporosis includes hormone therapy and the use of bone resorption inhibitors such as the bisphosphonates, and, in addition, stimulators of bone formation such as modified forms of parathyroid hormone (PTH). Another serious genetic bone disease is osteogenesis imperfecta, a heritable disease of bone characterized by recurring bone fractures. It is caused by mutations affecting the structure of the collagen type I molecule, and is the most common single gene defect causing bone disease. One of the bone cells, osteoclast is described histologically as a multinucleated, tartrate-resistant acid phosphatase (TRAP)-positive cell. The sole function of the osteoclast is to resorb bone. Osteoclast precursors are derived from the same stem cell hematopoietic precursors that can become granulocytes and monocytes/macrophages. Cell lines such as RAW 267.4 and MOPC-5 are available that represent osteoclast precursors, as these cells can form TRAP-positive multinucleated cells that resorb bone. Osteocytes are terminally differentiated osteoblasts, making up the majority of all bone cells. During osteocyte ontogeny, the matrix producing osteoblast becomes either a lining cell or a pre-osteocyte embedded in the newly formed osteoid.

UR - http://www.scopus.com/inward/record.url?scp=84882852265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882852265&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374145-5.00313-2

DO - 10.1016/B978-0-12-374145-5.00313-2

M3 - Chapter

SN - 9780123741455

VL - 3

SP - 2647

EP - 2662

BT - Handbook of Cell Signaling, 2/e

PB - Elsevier Inc.

ER -